Sr. Scientist at Eli Lilly and Company

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor’s degree in Biological Science or related field with a minimum of 5 years research experience with spectral flow cytometry, and deep immunology expertise
Master's degree in Biological Science or related field with a minimum of 3 years' experience with spectral flow cytometry, and deep immunology expertise
Authorized to work in the United States on a full-time basis
Experience with imaging flow cytometers (preferred)
Experience with high content imagers, confocal microscopes, and fluorescent slide scanners (preferred)
Demonstrated ability to work effectively both independently and as a team
Good communication skills including presenting results in team meetings
Excellent problem-solving skills and ability to effectively prioritize multiple tasks and projects
Strong self-start and self-management skills

Responsibilities

Provide flow cytometry and immunology expertise to support the portfolio
Guide users on appropriate instrumentation
Train users on acquisition and analysis
Generate data that drives project decisions
Lead flow cytometry training and data QC to new and existing users
Design flow panels in coordination with project scientists
Convey core capabilities to lead scientists to provide flow and imaging solutions to meet project needs
Collaborate across Lilly research sites and share key learnings and best practices
Keep up-to-date with emerging technologies and evaluate them in-house when appropriate

Skills

spectral flow cytometry

flow cytometry

immunology

imaging flow cytometers

high content imagers

confocal microscopes

fluorescent slide scanners

flow panel design

data QC

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free